Buds & Duds: Cannabis stocks on the rise Tuesday; Harvest One shares jump on promising epilepsy trial results

Cannabis stocks perked up on Tuesday, with broad-based gains across North American markets.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, gained 2% at 210.3 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF gained 1.25% to C$17.03, while the OTCQX Cannabis Index was up 1.9% to 699 points.

Buds

Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) shares were on the rise Tuesday after the firm announced its Satipharm Ltd subsidiary saw strong results from a clinical trial of its CBD GelPell capsules to treat children with epilepsy.

Shares of Harvest One were up 3.5% at C$0.59 in Toronto, and up 5.4% at US$0.44 in New York. 

The Phase 2 trial of children with treatment-resistant epilepsy found a median monthly seizure reduction of 82% over the 12-week treatment period when GelPell was added to patients’ current medications. More than half of the patients who started treatment saw a reduction

... read more at: https://www.proactiveinvestors.com/companies/news/900674/buds--duds-cannabis-stocks-on-the-rise-tuesday-harvest-one-shares-jump-on-promising-epilepsy-trial-results-900674.html

by

Leave a Reply